The effect of surface area expansion with pericardial membrane (preclude) in Ahmed glaucoma valve implant surgery

Journal of Glaucoma
Jeong-Min Hwang, Changwon Kee

Abstract

To compare the efficacy of Ahmed glaucoma valve (AGV) implant with and without surface area expansion using pericardial membrane (Preclude) in the treatment of complicated glaucoma. Ten eyes of AGV implant surgery using pericardial membrane (Preclude) that were designed to have surface area of 300 mm (e-AGV group) and 10 eyes of AGV implant surgery without surface area extension (AGV group) were enrolled in this prospective, randomized controlled trial study. Two (20%) of 10 eyes in the e-AGV group, and 8 (80%) of 10 eyes in the AGV group experienced the hypertensive phase (P = 0.007). Complete success rate was 90% in the e-AGV group and 70% in the AGV group (P = 0.291). Mean number of preoperative antiglaucoma medication was 2.4 +/- 0.5 and 1.9 +/- 0.3 for the e-AGV and AGV groups, respectively, and that of postoperative antiglaucoma medication was 0.1 +/- 0.3 and 0.4 +/- 0.7 for the e-AGV and AGV groups, respectively, at final follow-up (P = 0.229). Surface area expansion with pericardial membrane (Preclude) in AGV implant surgery resulted in a statistically significantly lower rate of hypertension without causing any postoperative complications.

References

Sep 1, 1992·Archives of Ophthalmology·M F SmithS P McGorray
Mar 15, 1991·American Journal of Ophthalmology·S MelamedM Blumenthal
Dec 1, 1990·Acta Ophthalmologica·P J AiraksinenA Tuulonen
Apr 1, 1988·Archives of Ophthalmology·J W Karesh, A M Putterman
Jan 1, 1988·Eye·R N DownesR L Burton
Jul 1, 1994·Ophthalmology·P S FellenbaumD K Heuer
Nov 1, 1993·Plastic and Reconstructive Surgery·F J SteinkoglerE Arocker-Mettinger
Aug 1, 1993·Archives of Ophthalmology·M Muñoz, R K Parrish
Feb 1, 1997·Journal of Glaucoma·R M FeldmanG Villanueva
Sep 1, 1995·Ophthalmology·S W SiegnerJ D Brandt
Oct 27, 1998·Ophthalmology·R S AyyalaW E Layden
Oct 28, 1999·Current Opinion in Ophthalmology·M H AssaadE J Rockwood
Jun 14, 2000·American Journal of Ophthalmology·R A HillL Liaw
Apr 1, 1995·Journal of Glaucoma·P S FellenbaumP P Lee

❮ Previous
Next ❯

Citations

Feb 3, 2006·Japanese Journal of Ophthalmology·Ricky W K LawDennis S C Lam
Jul 28, 2017·The Cochrane Database of Systematic Reviews·Victoria L TsengJoseph Caprioli
Jul 2, 2009·Korean Journal of Ophthalmology : KJO·Jong Joo LeeTae Woo Kim
Mar 17, 2015·Journal of Glaucoma·Hun Jae Won, Kyung Rim Sung

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.